No change in calf muscle passive stiffness after botulinum toxin injection in children with cerebral palsy

Developmental Medicine and Child Neurology

Volumn 53, Issue 6, 2011, Pages 553-558

  Alhusaini, Adel A A ^a   Crosbie, Jack ^a   Shepherd, Roberta B ^a   Dean, Catherine M ^a   Scheinberg, Adam ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A;

AGE; ANKLE; ARTICLE; CEREBRAL PALSY; CHILD; CONTROLLED STUDY; EVOKED MUSCLE RESPONSE; FEMALE; GASTROCNEMIUS MUSCLE; HEART MUSCLE COMPLIANCE; HUMAN; HYSTERESIS; MAJOR CLINICAL STUDY; MALE; MUSCLE STIFFNESS; PASSIVE MOVEMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RANGE OF MOTION; SCHOOL CHILD; SPASTICITY; TORQUE; VISCOELASTICITY;

BOTULINUM TOXINS, TYPE A; CEREBRAL PALSY; CHILD; CHILD, PRESCHOOL; ELECTROMYOGRAPHY; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; JOINTS; MALE; MUSCLE SPASTICITY; MUSCLE, SKELETAL; NEUROMUSCULAR AGENTS; PROSPECTIVE STUDIES; RANGE OF MOTION, ARTICULAR; STATISTICS, NONPARAMETRIC; TORQUE;

EID: 79955982122     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2011.03930.x     Document Type: Article

References (28)

1. Bax M, Goldstein M, Rosenbaum P, et al. Proposed definition and classification of cerebral palsy. Dev Med Child Neurol 2005; 47: 571-6.
2. Crenna P. Spasticity and 'spastic' gait in children with cerebral palsy. Neurosci Biobehav Rev 1998; 22: 571-8.
3. Dietz V, Berger W. Normal and impaired regulation of muscle-stiffness in gait - a new hypothesis about muscle hypertonia. Exp Neurol 1983; 79: 680-7.
4. Dietz V, Quintern J, Berger W. Electrophysiological studies of gait in spasticity and rigidity: evidence that altered mechanical properties of muscle contribute to hypertonia. Brain 1981; 104: 431-49.
5. Tardieu C, Lespargot A, Tabary C, Bret MD. Toe-walking in children with cerebral palsy: contributions of contracture and excessive contraction of triceps surae muscle. Phys Ther 1989; 69: 656-62.
6. Fonseca ST, Holt KG, Saltzman E, Fetters L. A dynamical model of locomotion in spastic hemiplegic cerebral palsy: influence of walking speed. Clin Biomech (Bristol, Avon) 2001; 16: 793-805.
7. Ward AB. Spasticity treatment with botulinum toxins. J Neural Transm 2008; 115: 607-16.
8. Satila H, Pietikainen T, Iisalo T, et al. Botulinum toxin type A injections into the calf muscles for treatment of spastic equinus in cerebral palsy: a randomized trial comparing single and multiple injection sites. Am J Phys Med Rehabil 2008; 87: 386-94.
9. Baker R, Jasinski M, Maciag-Tymecka I, et al. Botulinum toxin treatment of spasticity in diplegic cerebral palsy: a randomized, double-blind, placebo-controlled, dose-ranging study. Dev Med Child Neurol 2002; 44: 666-75.
10. Tedroff K, Granath F, Forssberg H, Haglund-Akerlind Y. Long-term effects of botulinum toxin A in children with cerebral palsy. Dev Med Child Neurol 2009; 51: 120-7.
11. Legerlotz K, Matthews KG, McMahon CD, Smith HK. Botulinum toxin-induced paralysis leads to slower myosin heavy chain isoform composition and reduced titin content in juvenile rat gastrocnemius muscle. Muscle Nerve 2009; 39: 472-9.
12. Zhang LQ, Wang G, Nishida T, Xu D, Sliwa JA, Rymer WZ. Hyperactive tendon reflexes in spastic multiple sclerosis: measures and mechanisms of action. Arch Phys Med Rehabil 2000; 81: 901-9.
13. Aquino CF, Goncalves GG, Fonseca ST, Mancini MC. Analysis of the relation between flexibility and passive stiffness of the hamstrings. Rev Bras Med Esporte 2006; 12: 175-9.
14. Gavronski G, Veraksits A, Vasar E, Maaroos J. Evaluation of viscoelastic parameters of the skeletal muscles in junior triathletes. Physiol Meas 2007; 28: 625-37.
15. Alhusaini AAA, Crosbie J, Shepherd RB, Dean CM, Scheinberg A. Mechanical properties of the plantarflexor musculotendinous unit during passive dorsiflexion in children with cerebral palsy compared with typically developing children. Dev Med Child Neurol 2010; 52: e101-6.
16. Graham HK, Aoki KR, Autti-Rämö I, et al. Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait Posture 2000; 11: 67-79.
17. Moseley AM, Crosbie J, Adams R. Normative data for passive ankle plantarflexion-dorsiflexion flexibility. Clin Biomech (Bristol, Avon) 2001; 16: 514-21.
18. Hermens HJ, Freriks B, Disselhorst-Klug C, Rau G. Development of recommendations for SEMG sensors and sensor placement procedures. J Electromyogr Kinesiol 2000; 10: 361-74.
19. Moseley A, Adams R. Measurement of passive ankle dorsiflexion: procedure and reliability. Aust J Physiother 1991; 37: 175-81.
20. Sinkjaer T, Toft E, Andreassen S, Hornemann BC. Muscle stiffness in human ankle dorsiflexors: intrinsic and reflex components. J Neurophysiol 1988; 60: 1110-21.
21. Linder-Lucht M, Kirschner J, Herrmann J, et al. 'Why do children with cerebral palsy discontinue therapy with botulinum toxin A?'. Dev Med Child Neurol 2006; 48: 319-20.
22. Dodd SL, Selsby J, Payne A, Judge A, Dott C. Botulinum neurotoxin type A causes shifts in myosin heavy chain composition in muscle. Toxicon 2005; 46: 196-203.
23. Becher JG, Harlaar J, Lankhorst GJ, Vogelaar TW. Measurement of impaired muscle function of the gastrocnemius, soleus, and tibialis anterior muscles in spastic hemiplegia: a preliminary study. J Rehabil Res Dev 1998; 35: 314-26.
24. Ackman JD, Russman BS, Thomas SS, et al. Comparing botulinum toxin A with casting for treatment of dynamic equinus in children with cerebral palsy. Dev Med Child Neurol 2005; 47: 620-7.
25. Rabita G, Dupont L, Thevenon A, Lensel-Corbeil G, Perot C, Vanvelcenaher J. Quantitative assessment of the velocity-dependent increase in resistance to passive stretch in spastic plantarflexors. Clin Biomech (Bristol, Avon) 2005; 20: 745-53.
26. Abellaneda S, Guissard N, Duchateau J. The relative lengthening of the myotendinous structures in the medial gastrocnemius during passive stretching differs among individuals. J Appl Physiol 2009; 106: 169-77.
27. Riemann BL, DeMont RG, Ryu K, Lephart SM. The effects of sex, joint angle, and the gastrocnemius muscle on passive ankle joint complex stiffness. J Athl Train 2001; 36: 369-75.
28. Zhao H, Ren YP, Wu YN, Liu SQ, Zhang LQ. Ultrasonic evaluations of Achilles tendon mechanical properties poststroke. J Appl Physiol 2009; 106: 843-9.